305 related articles for article (PubMed ID: 21443269)
1. Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes.
Liu X; Pietsch KE; Sturla SJ
Chem Res Toxicol; 2011 May; 24(5):726-36. PubMed ID: 21443269
[TBL] [Abstract][Full Text] [Related]
2. Profiling patterns of glutathione reductase inhibition by the natural product illudin S and its acylfulvene analogues.
Liu X; Sturla SJ
Mol Biosyst; 2009 Sep; 5(9):1013-24. PubMed ID: 19668867
[TBL] [Abstract][Full Text] [Related]
3. Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates.
Pietsch KE; Neels JF; Yu X; Gong J; Sturla SJ
Chem Res Toxicol; 2011 Nov; 24(11):2044-54. PubMed ID: 21939268
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
5. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue.
Nordberg J; Zhong L; Holmgren A; Arnér ES
J Biol Chem; 1998 May; 273(18):10835-42. PubMed ID: 9556556
[TBL] [Abstract][Full Text] [Related]
6. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
7. Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defense.
Chandler JD; Nichols DP; Nick JA; Hondal RJ; Day BJ
J Biol Chem; 2013 Jun; 288(25):18421-8. PubMed ID: 23629660
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin reductase inhibitors: a patent review.
Zhang B; Zhang J; Peng S; Liu R; Li X; Hou Y; Han X; Fang J
Expert Opin Ther Pat; 2017 May; 27(5):547-556. PubMed ID: 27977313
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
12. Diphenyl diselenide protects against methylmercury-induced inhibition of thioredoxin reductase and glutathione peroxidase in human neuroblastoma cells: a comparison with ebselen.
Meinerz DF; Branco V; Aschner M; Carvalho C; Rocha JBT
J Appl Toxicol; 2017 Sep; 37(9):1073-1081. PubMed ID: 28383113
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
Liu Y; Li Y; Yu S; Zhao G
Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
[TBL] [Abstract][Full Text] [Related]
14. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
16. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase.
Branco V; Canário J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2012 Feb; 52(4):781-93. PubMed ID: 22198265
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells.
Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J
Biochem Pharmacol; 2016 Feb; 102():34-44. PubMed ID: 26686580
[TBL] [Abstract][Full Text] [Related]
19. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.
Rice KP; Klinkerch EJ; Gerber SA; Schleicher TR; Kraus TJ; Buros CM
Mol Cell Biochem; 2012 Nov; 370(1-2):199-207. PubMed ID: 22864532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
